SYRS stock icon

Syros Pharmaceuticals
SYRS

$6.53
0.15%

Market Cap: 175M

 

About: Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.

Employees: 68

0
Funds holding %
of 6,702 funds
0
Analysts bullish %
of 4 analysts
News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

5,300% more call options, than puts

Call options by funds: $162K | Put options by funds: $3K

267% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 6

200% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 7

100% more funds holding in top 10

Funds holding in top 10: 1 [Q4 2023] → 2 (+1) [Q1 2024]

28% more funds holding

Funds holding: 58 [Q4 2023] → 74 (+16) [Q1 2024]

6.4% more ownership

Funds ownership: 74.01% [Q4 2023] → 80.41% (+6.4%) [Q1 2024]

24% less capital invested

Capital invested by funds: $147M [Q4 2023] → $112M (-$34.9M) [Q1 2024]

Research analyst outlook

4 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$13
99%
upside
Avg. target
$14.50
122%
upside
High target
$15
130%
upside

4 analyst ratings

positive
100%
neutral
0%
negative
0%
HC Wainwright & Co.
Andrew Fein
130%upside
$15
Buy
Reiterated
26 Jun 2024
HC Wainwright & Co.
Andrew Fein
130%upside
$15
Buy
Reiterated
15 May 2024
Piper Sandler
Edward Tenthoff
99%upside
$13
Overweight
Reiterated
3 Apr 2024
HC Wainwright & Co.
Andrew Fein
130%upside
$15
Buy
Reiterated
1 Apr 2024

Financial journalist opinion